Key Takeaways
- Glaucoma drainage device implantation achieved a 76% overall surgical success rate and was associated with significant reductions in intraocular pressure in children with glaucoma.
- Medication burden decreased after surgery, although longer follow-up was linked to lower success rates and increasing medication requirements over time.
Glaucoma drainage device (GDD) implantation in children with glaucoma was associated with a 76% overall surgical success rate, along with substantial reductions in intraocular pressure (IOP) and the need for glaucoma medications in a recent study.
Researchers analyzed data from 1,082 pediatric patients (1,233 eyes) who underwent GDD implantation for pediatric glaucoma. The pooled surgical success rate across all devices was 76%. Success rates ranged from 70.7% with the Aurolab aqueous drainage implant to 82.3% with the Baerveldt glaucoma implant. Other reported success rates were 78.9% for the Ahmed ClearPath, 73.0% for the Ahmed glaucoma valve, and 80.0% for the Paul glaucoma implant.
Across studies, GDD implantation reduced IOP by a pooled mean of 16.14 mmHg and decreased antiglaucoma medication use by a mean of 1.63 medications. Meta-regression analysis showed that longer follow-up duration was associated with lower surgical success rates and smaller reductions in medication burden.
The authors noted that substantial variability among studies, inconsistent definitions of success, and declining outcomes over time warrant cautious interpretation, particularly when comparing devices.
Reference
Ozer F, Sener H, Unlu M, et al. Glaucoma Drainage Devices in Pediatric Glaucoma: A Systematic Review and Meta-Analysis. Semin Ophthalmol. 2026;1-16. doi: 10.1080/08820538.2026.2692109. Epub ahead of print. PMID: 42321623.
Related Content
